Cytodyn Inc (CYDY)

[Northstar42]

The people who know what is going on are obviously locked down by NDAs. That said, if you think it through, there are only two paths. First, either a strategic buyer, such as Gilead, buys the company or second, sufficient financing is secured to take PRO140 to market. Pulling the RS suggests management and their advisors determined that the first path is more likely than the second, so, if the path leads to a BO, why take the risk of a short attack and spend significant capital on up listing. The up listing would benefit nobody. IMO clearer heads prevailed and to their credit, in the end, management made the right decision. The next key decision, will be to select a financial firm to help the company achieve its objectives and there are many to choose from.